Lv2
108 积分 2022-04-19 加入
Claudin 18.2 as a novel therapeutic target
4小时前
待确认
An in situ engineered chimeric IL-2 receptor potentiates the tumoricidal activity of proinflammatory CAR macrophages in renal cell carcinoma
10天前
已完结
CAR therapies: development, design, and implementation
1个月前
已完结
The new era of immunological treatment, last updated and future consideration of CAR T cell-based drugs
1个月前
已完结
Scarless circular mRNA-based CAR-T cell therapy elicits superior anti-tumor efficacy
2个月前
已完结
Current progress and challenges of immunotherapy in gastric cancer: A focus on CAR-T cells therapeutic approach
3个月前
已完结
Small circular RNAs as vaccines for cancer immunotherapy
3个月前
已完结
Research advances in branched-chain amino acid metabolism in tumors
5个月前
已完结
Synergically enhanced anti-tumor immunity of in vivo CAR by circRNA vaccine boosting
7个月前
已完结
mRNA Lipid Nanoparticles for Ex Vivo Engineering of Immunosuppressive T Cells for Autoimmunity Therapies
7个月前
已完结
皖公网安备34019202002308
